Article
A self-amplifying RNA vaccine prevents enterovirus D68 infection and disease in preclinical models
7 Aug 2024
Abstract excerpt
The recent emergence and rapid response to severe acute respiratory syndrome coronavirus 2 was enabled by prototype pathogen and vaccine platform approaches, driven by the preemptive application of RNA vaccine technology to the related Middle East respiratory syndrome coronavirus. Recently, the National Institutes of Allergy and Infectious Diseases identified nine virus families of concern, eight enveloped virus...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
